Sponsored Content |Webinar | Intra-Vascular Ultrasound (IVUS)| June 27, 2023

This webinar took place on June 27 — it is now available for on-demand viewing.

Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery.

Preventing contrast induced nephropathy and managing patients with chronic kidney disease remain major challenges in the cardiac catheterization lab. In recent years, contrast supply shortages have presented a new challenge to care delivery. When considering these challenges, and as quality metrics in our labs face more scrutiny, there are existing technologies and best practices such as a variable rate contrast delivery systems and HD IVUS that can be used to manage workflow and improve patient outcomes.

The ACC Interventional Council’s recent statement recommending that intracoronary imaging be a routine part of clinical practice further reinforces the need for adoption of intracoronary. Using a case-based approach, the faculty will demonstrate how to use the ACIST CVi contrast delivery system, HDi high definition IVUS and diagnostic and post-PCI physiologic assessment to reduce contrast usage, improve AKI rates and deliver optimized patient outcomes.

REGISTER FOR THE WEBINAR

Learning Objectives

By the end of this webinar, participants will understand that high-quality care starts at the point of education and can transform cardiovascular imaging. Attendees will see how optimized workflows can improve quality and will be able to:

  • To understand the benefits of implementing a variable rate contrast delivery system in the cath lab.
  • To understand the clinical benefits of HD IVUS utilization and how to implement a standardized workflow for effective use.
  • To understand how HD IVUS and physiologic testing can be used to improve patient outcomes and reduce contrast utilization.

Featured Speakers

headshot

Dr. Matheen A. Khuddus
Director of Cardiovascular Research/Director of the Cardiac Catheterization Lab
HCA Florida North Florida Hospital and the Cardiac & Vascular Institute, Gainesville, Fla.

Dr. Khuddus is an interventional cardiologist who currently serves as the Director of Cardiovascular Research and the Director of the Cardiac Catheterization Lab as well as a National Physician Director for HCA Healthcare. He is a fellow of the ACC and SCAI.  He is board certified in Cardiovascular Medicine, Interventional Cardiology, and Internal Medicine.  He is also an AHSCP Clinical Hypertension Specialist.


headshot

Dr. Darshan Doshi
Director of Complex Coronary Artery Disease
Massachusetts General Hospital, Boston, Mass.

Dr. Doshi is an interventional cardiologist who specializes in complex coronary intervention, specifically chronic total occlusions, surgical turndowns, ultralow and zero contrast stenting procedures, and treatment of recurrent stent blockages. He is the Director of Complex Coronary Artery Disease at MGH. He is board certified in Cardiovascular Medicine and Interventional Cardiology.

About ACIST

Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. ACIST informs interventional decisions during peripheral, cardiovascular disease and structural heart procedures. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.


Related Content

News | Heart Failure

September 15, 2023 — A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease ...

Home September 15, 2023
Home
News | Heart Failure

September 13, 2023 — Socioeconomic status (education, income, employment status and health insurance) appears to be an ...

Home September 13, 2023
Home
News | Heart Failure

September 8, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home September 08, 2023
Home
News | Heart Failure

September 5, 2023 — Cedars-Sinai investigators are leaders in the innovation and use of transcatheter aortic valve ...

Home September 05, 2023
Home
News | Heart Failure

August 30, 2023 — “Joining forces to protect the heart – this was our mission for this year’s ESC Congress,” said ...

Home August 30, 2023
Home
News | Heart Failure

August 29, 2023 — The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online ...

Home August 29, 2023
Home
News | Heart Failure

August 28, 2023 — Ferric carboxymaltose(FCM) did not improve a hierarchical outcome of death, heart failure ...

Home August 28, 2023
Home
News | Heart Failure

July 28, 2023 — The Society of Thoracic Surgeons has launched its next-generation Operative Risk Calculator to assess ...

Home July 28, 2023
Home
News | Heart Failure

July 19, 2023 — The U.S. Food and Drug Administration (FDA) is recommending health care providers, laboratory personnel ...

Home July 19, 2023
Home
News | Heart Failure

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on Quidel Cardiovascular is ...

Home July 18, 2023
Home
Subscribe Now